Price
No data yet.
Social Signal Score
Revenue
$1.14B-68.22%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Ester Baiget
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Employees
- 11,641
- Beta
- 0.62
- Country
- DK
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 22.86
Financials
Revenue
$1.14B-68.2%Net Income
$202.37M-74.5%EBITDA
$424.98M-68.9%Free Cash Flow
$89.45M-92.2%EPS (diluted)
$0.43-84.8%Shares Outstanding (diluted)
466.23M+66.1%Operating Expenses
$367.79MCash & Debt
$329.74MReturn of Capital
$269.46MDividend per Share
$0.10Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $4.16B | $583.60M | $1.35 |
| 2024 | $513.65M | $40.97M | $0.15 |
| 2023 | $17.90B | $3.02B | $1.46 |
| 2022 | $17.55B | $3.68B | $13.29 |
| 2021 | $14.95B | $3.15B | $11.32 |
| 2020 | $14.01B | $2.83B | $10.07 |
| 2019 | $14.37B | $3.15B | $11.06 |
| 2018 | $14.39B | $3.23B | $11.11 |
| 2017 | $14.53B | $3.12B | $10.56 |
| 2016 | $14.14B | $3.05B | $10.15 |
| 2015 | $14.00B | $2.82B | $9.23 |
| 2014 | $12.46B | $2.53B | $8.10 |
| 2013 | $11.75B | $2.20B | $7.01 |
| 2012 | $11.23B | $2.02B | $6.42 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from NVZMY's reported EPS growth of -11.3% a year over 13 years.
- EPS in 5 years
- $0.77
- Implied price
- $13.91
- Return from $69.51
- -27.5% a year
To earn 15.0% a year on these assumptions you'd need to buy at $6.92 — -90.0% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 15 | 18 | 21 | 24 |
|---|---|---|---|---|---|
| -21.3% | -40.7% | -38.0% | -35.7% | -33.7% | -31.9% |
| -16.3% | -36.9% | -34.0% | -31.6% | -29.5% | -27.5% |
| -11.3% | -33.2% | -30.1% | -27.5% | -25.2% | -23.2% |
| -6.3% | -29.4% | -26.2% | -23.4% | -21.0% | -18.9% |
| -1.3% | -25.6% | -22.2% | -19.3% | -16.8% | -14.6% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
120Social Signal Score
Mentions (1)
- Newsseekingalpha.com·5h ago·Positive
Novozymes A/S (NVZMY) Q2 2026 Earnings Call Transcript Novozymes A/S (NVZMY) Q2 2026 Earnings Call Transcript
View source ↗
Earnings
Thu, Nov 5(in 3 months)
Consensus estimate $0.61 per share
Typical surprise -25.8% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 20$0.44 vs $0.60miss
- Tue, May 5$0.51 vs $0.62miss
- Wed, Feb 25$0.35 vs $0.79miss
- Thu, Nov 6$0.47 vs $0.64miss
- Thu, Aug 21$0.42 vs $0.67miss
- Thu, May 8$0.47 vs $0.44beat
Estimates and results for NVZMY via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.